Results 171 to 180 of about 24,684 (197)

Ranibizumab

Reactions Weekly, 2016
  +5 more sources

Ranibizumab

Reactions Weekly, 2022
openaire   +2 more sources

Ranibizumab

Reactions Weekly, 2021
openaire   +1 more source

Ranibizumab

Reactions Weekly, 2011
  +4 more sources

Ranibizumab

Reactions Weekly, 2010
openaire   +2 more sources

In-vitro characterization of ranibizumab release from the Port Delivery System

Journal of Controlled Release, 2022
Katie F Maass, Judit Horvath, Jennifer C Rea   +2 more
exaly  

Ranibizumab

Reactions Weekly, 2019
  +5 more sources

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2022
Nancy Holekamp, Daniel Miller, Dante Pieramici   +2 more
exaly  

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial

Lancet, The, 2019
Andreas Stahl, Domenico Lepore, Michael F Chiang   +2 more
exaly  

Ranibizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine, 2006
Philip J Rosenfeld, Jeffrey S Heier
exaly